Patents Assigned to Diagnostic Data, Inc.
  • Treatment of arthritis and allied conditions with xenylsalate
    Patent number: 4073897
    Abstract: Xenylsalate hydrochloride taken systemically, either orally or subcutaneously, has been found to be an effective relief for the symptoms of arthritis and allied conditions. Substantially no side effects have been noted.
    Type: Grant
    Filed: November 15, 1976
    Date of Patent: February 14, 1978
    Assignee: Diagnostic Data, Inc.
    Inventor: Arthur Karler
  • N-carbamylated orgotein
    Patent number: 4070459
    Abstract: N-carbamylated orgotein, like the native protein, possesses superoxide dismutase and anti-inflammatory activity.
    Type: Grant
    Filed: December 9, 1975
    Date of Patent: January 24, 1978
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams
  • Alkylated orgotein
    Patent number: 4042689
    Abstract: N-alkylated orgotein, like the native protein, possesses superoxide dismutase and anti-inflammatory activity.
    Type: Grant
    Filed: September 9, 1975
    Date of Patent: August 16, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams
  • Esterified orgotein
    Patent number: 4022888
    Abstract: Esterified orgotein, like the native protein, possesses Superoxide Dismutase and anti-inflammatory activity.
    Type: Grant
    Filed: September 9, 1975
    Date of Patent: May 10, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams
  • Radioactive labeled orgotein
    Patent number: 4022877
    Abstract: Orgotein labeled with .sup.99M Tc, or with a radioactive iodine isotope, preferably .sup.131 I, is useful in scintigraphy for tissue visualization, especially the kidneys.
    Type: Grant
    Filed: September 9, 1975
    Date of Patent: May 10, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams
  • Reduction of superoxide accumulation caused by smoke inhalation
    Patent number: 4022224
    Abstract: The toxic effects of smoke inhalation are reduced by the inhalation of an amount of orgotein effective to reduce the amount of superoxide radicals produced in the respiratory tract by the smoke.
    Type: Grant
    Filed: September 9, 1975
    Date of Patent: May 10, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Mark G. Saifer, Lewis D. Williams, Wolfgang Huber
  • Acylated orgotein
    Patent number: 4017605
    Abstract: N-acylated orgotein, although possessing substantially less SODase activity than the native protein, possesses antiinflammatory activity comparable to that of orgotein.
    Type: Grant
    Filed: September 20, 1974
    Date of Patent: April 12, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams
  • Cross-linked orgotein
    Patent number: 4009267
    Abstract: Orgotein cross-linked with itself or with non-antigenic injectable serum or tissue protein has a substantially longer half-life in the blood after injection than orgotein.
    Type: Grant
    Filed: September 9, 1975
    Date of Patent: February 22, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams